Literature DB >> 36018493

Prevalence and species distribution of Candida bloodstream infection in children and adults in two teaching university hospitals in Egypt: first report of Candida kefyr.

Nashwa Mohamed Reda1, Reem Mostafa Hassan1, Sherifa Tarek Salem2, Reham Hamed A Yousef1.   

Abstract

BACKGROUND: Candidemia is a pervasive problem associated with significant morbidity and mortality in health care settings. This study aimed to determine the changing distribution of Candida species and the emergence of uncommon species.
METHODS: This was a cross-sectional study performed in two Cairo University hospitals between 2019 and 2020. All Candida species isolates recovered from blood cultures of adults and pediatrics patients admitted to the hospitals were included. Candida isolates were identified by chromogenic Candida agar and Vitek2 YST identification card. Candida kefyr was confirmed by chip array.
RESULTS: Candida species were responsible for 1.6% of bloodstream infections in adults and 10.8% in pediatric patients. C. albicans was the most prevalent species representing 27.8% in adults and 48.3% in pediatrics. Non-albicans species (NAC) represented the most isolated Candida species among adults and pediatrics (72.2% and 51.6%, respectively) with the predominance of C. tropicalis (27.8% and 22.5%, respectively) followed by C. parapsilosis (16.7% and 10.8%, respectively). The uncommon Candida, which is Candida species other than C. albicans, C. parapsilosis, C. tropicalis, C. glabrata, and C. krusei, represents 16.6% and 14% of all candidemia in adults and pediatrics, respectively. Only one of each of C. lusitaniae, C. utilis, and C. kefyr were detected in adults. C. lusitaniae was the most frequently recovered uncommon Candida among pediatrics resulting in 6.4% of candidemia followed by C. famata (4.3%), C. utilis (2.2%), and C. kefyr (1.1%).
CONCLUSIONS: C. albicans is still the primary species isolated from pediatrics and adults with candidemia despite the considerable shift to the non-albicans species. C. tropicalis and C. parapsilosis are the most prevalent NAC. The increased prevalence of uncommon Candida species is alarming and necessitates a prompt stewardship program.
© 2022. The Author(s).

Entities:  

Keywords:  Candida albicans; Candida kefyr; Candida parapsilosis; Candidemia; Non-albicans Candida; Uncommon Candida

Year:  2022        PMID: 36018493     DOI: 10.1007/s15010-022-01888-7

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   7.455


  46 in total

1.  Increasing incidence of candidaemia and shifting epidemiology in favor of Candida non-albicans in a 9-year period (2009-2017) in a university Greek hospital.

Authors:  Matthaios Papadimitriou-Olivgeris; Anastasia Spiliopoulou; Fevronia Kolonitsiou; Christina Bartzavali; Anastasia Lambropoulou; Panagiota Xaplanteri; Evangelos D Anastassiou; Markos Marangos; Iris Spiliopoulou; Myrto Christofidou
Journal:  Infection       Date:  2018-09-08       Impact factor: 3.553

2.  Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study.

Authors:  B H Tan; A Chakrabarti; R Y Li; A K Patel; S P Watcharananan; Z Liu; A Chindamporn; A L Tan; P-L Sun; U-I Wu; Y-C Chen
Journal:  Clin Microbiol Infect       Date:  2015-06-20       Impact factor: 8.067

3.  A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies.

Authors:  M N Gamaletsou; T J Walsh; T Zaoutis; M Pagoni; M Kotsopoulou; M Voulgarelis; P Panayiotidis; T Vassilakopoulos; M K Angelopoulou; M Marangos; A Spyridonidis; D Kofteridis; A Pouli; D Sotiropoulos; P Matsouka; A Argyropoulou; S Perloretzou; K Leckerman; A Manaka; P Oikonomopoulos; G Daikos; G Petrikkos; N V Sipsas
Journal:  Clin Microbiol Infect       Date:  2013-07-24       Impact factor: 8.067

4.  Attributable mortality of nosocomial candidemia, revisited.

Authors:  Olafur Gudlaugsson; Shane Gillespie; Kathleen Lee; Jeff Vande Berg; Jianfang Hu; Shawn Messer; Loreen Herwaldt; Michael Pfaller; Daniel Diekema
Journal:  Clin Infect Dis       Date:  2003-10-08       Impact factor: 9.079

5.  Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungals.

Authors:  Berdieke Goemaere; Pierre Becker; Eric Van Wijngaerden; Johan Maertens; Isabel Spriet; Marijke Hendrickx; Katrien Lagrou
Journal:  Mycoses       Date:  2017-11-15       Impact factor: 4.377

6.  Multistate point-prevalence survey of health care-associated infections.

Authors:  Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

Review 7.  Invasive candidiasis as a cause of sepsis in the critically ill patient.

Authors:  Julie Delaloye; Thierry Calandra
Journal:  Virulence       Date:  2013-08-27       Impact factor: 5.882

8.  Emergence of non-albicans Candida species in neonatal candidemia.

Authors:  Deepak Juyal; Munesh Sharma; Shekhar Pal; Vyas Kumar Rathaur; Neelam Sharma
Journal:  N Am J Med Sci       Date:  2013-09

9.  Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA.

Authors:  Dong Sik Jung; Dimitrios Farmakiotis; Ying Jiang; Jeffrey J Tarrand; Dimitrios P Kontoyiannis
Journal:  Emerg Infect Dis       Date:  2015-11       Impact factor: 6.883

10.  Candidemia due to uncommon Candida species in children: new threat and impacts on outcomes.

Authors:  Ming-Horng Tsai; Jen-Fu Hsu; Lan-Yan Yang; Yu-Bin Pan; Mei-Yin Lai; Shih-Ming Chu; Hsuan-Rong Huang; Ming-Chou Chiang; Ren-Huei Fu; Jang-Jih Lu
Journal:  Sci Rep       Date:  2018-10-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.